Europe Liquid Biopsy Market by Cancer Type (Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers) by Sample Type (Blood, Urine, Plasma, Saliva and Cerebrospinal) by Diagnostic Approach (Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles), By End Users (Reference Laboratories, Hospital/Physician Laboratories, Academic and Research Centers, and Other End Users) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Liquid Biopsy Market by Cancer Type (Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers) by Sample Type (Blood, Urine, Plasma, Saliva and Cerebrospinal) by Diagnostic Approach (Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles), By End Users (Reference Laboratories, Hospital/Physician Laboratories, Academic and Research Centers, and Other End Users) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 952 | Pages: 142 | October 2016 | Region: Europe


The Europe Liquid Biopsy market is expected to increase at a CAGR of 21.45% in the forecast period of 2016-2021 and reach a value of USD 358.69 million by 2021 from USD 135.75 million in 2016. Europe region is also showing high growth in liquid biopsy in future. Increase in population, patients suffering from cancer, increasing awareness within the people, and the need to detect and recover cancer are some factors driving the market. Lung cancer is one of the most common diseases in European countries. European market is geographically segmented into UK, France, Italy, Germany and Spain.

Technological advances over the past two decades are starting to change by flagging the way for liquid biopsy. Liquid biopsies also present with a unique opportunity to move forward with the understanding of metastatic disease development, especially to identify the pathways involved in cell invasiveness and metastatic competence. 

Use of liquid biopsies is rapidly increasing as it has attracted the researchers and life sciences companies, as evidence mounts that a simple blood draw is now able to reveal whether a therapy has actually worked or not. Early stage detection of cancer is now possible with the technique of liquid biopsies. This could lead to establishment of a longer treatment and healthier chances of extending the survival period of the patient.

The liquid biopsy market is mainly segmented by types of cancer into Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers. By Diagnostic approach they can be classified as Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles. Based on end users, the market is segmented into reference laboratories, hospital/physician laboratories, academic and research centers, and other end users. The market is bifurcate into blood, urine, plasma, saliva and Cerebrospinal fluid based upon sample type. CTCs (Circulating Tumour cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period.     

The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Cancer Type                                         

                                5.1.1 Lung Cancer                           

                                5.1.2 Pancreatic Cancer                

                                5.1.3 Leukemia                

                                5.1.4 Other Visceral Cancers                       

                5.2 By Sample Type                                        

                                5.2.1 Blood                        

                                5.2.2 Urine                         

                                5.2.3 Plasma                      

                                5.2.4 Saliva                         

                                5.2.5 Cerebrospinal                        

                5.3 By Diagnostic Approach                                        

                                5.3.1 Circulating Tumour cells (CTC)                        

                                5.3.2 Circulating Tumour DNA (ctDNA)                  

                                5.3.3 RNA in exosomes                 

                                5.3.4 Extra-Cellular Vesicles                        

                5.4 By End Users                                             

                                5.4.1 Reference Laboratories                     

                                5.4.2 Hospital/Physician Laboratories                     

                                5.4.3 Academic and Research Centers                    

                                5.4.4 Other End Users                   

6. Geographical Analysis                                                              

                                6.1 Introduction                              

                                6.2 U.K                

                                6.3 Spain                             

                                6.4 Germany                     

                                6.5 Italy                               

                                6.6 France                          

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8. Market Leaders' Analysis                                                        

                8.1 Janssen Diagnostics                                

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Qiagen                                         

                8.3 Rarecells SAS                                             

                8.4 Silicon Biosystems                                   

                8.5 SRI International                                      

                8.6 Myriad Genetics                                      

                8.7 Natera                                          

                8.8 Personal Genome Diagnostics                                            

                8.9 Sysmex Inostics                                        

                8.10 Trovagene                                

                8.11 Exosome Diagnostics                                           

                8.12 HansaBiomed OU                                  

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Liquid Biopsy Market By Region, From 2016-2021 (USD Million)
  2. Europe Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  3. Europe Lung Cancer Market By Region, From 2016-2021 (USD Million)
  4. Europe Pancreatic Cancer Market By Region, From 2016-2021 (USD Million)
  5. Europe Leukemia Market By Region, From 2016-2021 (USD Million)
  6. Europe Other Visceral Cancers Market By Region, From 2016-2021 (USD Million)
  7. Europe Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  8. Europe Blood Market By Region, From 2016-2021 (USD Million)
  9. Europe Urine Market By Region, From 2016-2021 (USD Million)
  10. Europe Plasma Market By Region, From 2016-2021 (USD Million)
  11. Europe Saliva Market By Region, From 2016-2021 (USD Million)
  12. Europe Cerebrospinal Market By Region, From 2016-2021 (USD Million)
  13. Europe Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  14. Europe Circulating Tumour cells (CTC) Market By Region, From 2016-2021 (USD Million)
  15. Europe Circulating Tumour DNA (ctDNA) Market By Region, From 2016-2021 (USD Million)
  16. Europe RNA in exosomes Market By Region, From 2016-2021 (USD Million)
  17. Europe Extra-Cellular Vesicles Market By Region, From 2016-2021 (USD Million)
  18. Europe Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  19. Europe Reference Laboratories Market By Region, From 2016-2021 (USD Million)
  20. Europe Hospital/Physician Laboratories Market By Region, From 2016-2021 (USD Million)
  21. Europe Academic and Research Centers Market By Region, From 2016-2021 (USD Million)
  22. Europe Other End Users Market By Region, From 2016-2021 (USD Million)
  23. U.K Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  24. U.K Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  25. U.K Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  26. U.K Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  27. Spain Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  28. Spain Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  29. Spain Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  30. Spain Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  31. Germany Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  32. Germany Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  33. Germany Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  34. Germany Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  35. Italy Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  36. Italy Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  37. Italy Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  38. Italy Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
  39. France Liquid Biopsy Market By Cancer Type, From 2016-2021 (USD Million)
  40. France Liquid Biopsy Market By Sample Type, From 2016-2021 (USD Million)
  41. France Liquid Biopsy Market By Diagnostic Approach, From 2016-2021 (USD Million)
  42. France Liquid Biopsy Market By End Users, From 2016-2021 (USD Million)
Latin America Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mul...
Asia Pacific Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mult...
Europe Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex,...
North America Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mul...
Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwi...
Middle East And Africa Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridizat...
Latin America Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End...
Asia Pacific Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End ...
Europe Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (...
North America Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End...
Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospita...
Middle East And Africa RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.